The Beauty Health Company Reports Strong First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Qualcomm to issue warrant to Amazon for up to 25M shares
- Trump says Canada's Bombardier must build jets in US or lose market access
- Wall St slips as Gulf tensions send oil to over six-week high
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
The Beauty Health Company (SKIN) PT Lowered to $24 at Jefferies
May 11, 2022 8:25 AM EDTJefferies analyst Stephanie Wissink lowered the price target on The Beauty Health Company (NASDAQ: SKIN) to $24.00 (from $27.00) while maintaining a Buy rating following earnings.
The analyst commented, "Q1 sales +59% Y/Y driven by system sales +63% Y/Y were ahead of estimates & reflect strong... More
The Beauty Health Company (SKIN) PT Lowered to $20 at Cowen
May 11, 2022 8:04 AM EDTCowen analyst Oliver Chen lowered the price target on The Beauty Health Company (NASDAQ: SKIN) to $20.00 (from $27.00) while maintaining a Outperform rating following earnings.
The analyst commented, "We are encouraged by the early reception of Syndeo, but FY22 will be an investment... More
The Beauty Health Company (SKIN) Q1 Revenues Beats, Guides FY Revenues Higher
May 10, 2022 4:43 PM EDTThe Beauty Health Company (NASDAQ: SKIN) reported Q1 revenue of $75.4 million versus the consensus estimate of $68.37 million.
GUIDANCE:
The Beauty Health Company sees FY2022 revenue of $333-340 million, versus the consensus of $327.2 million.
For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.
... More